Related Experiment Video
Updated: Jun 6, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Primary cytomegalovirus infectious colitis complicating Crohn's disease successfully treated with oral valganciclovir
Venkataraman Subramanian1, Caroline Finlayson, Thomas Harrison
1Department of Gastroenterology, St George's Healthcare NHS Trust, Blackshaw Road, London SW17 0QT, United Kingdom. venkat@nottingham.ac.uk
Abstract:
Most cases of cytomegalovirus (CMV) colitis that develop in patients with inflammatory bowel disease (IBD) are caused by reactivation of a latent virus. Primary CMV infections are rare in adult patients. Treatment with immunosuppressive agents increases the infection risk in patients with IBD. We present a 26 year old lady with primary CMV colitis, superimposed on underlying Crohn's colitis. The diagnosis was confirmed by a viral-like prodrome, a positive CMV IgM titer, presence of low avidity IgG antibodies to CMV, high CMV DNA titers in the plasma, and immunohistological detection of CMV positive cells in her colonic mucosa. The patient responded to initial treatment with intravenous ganciclovir with a fall in plasma levels of CMV DNA, treatment was completed with oral valganciclovir until plasma CMV DNA levels became undetectable.
Insights
Primary cytomegalovirus (CMV) colitis is rare in adults with inflammatory bowel disease (IBD). This case highlights a young woman with Crohn's colitis who experienced a primary CMV infection, successfully treated with antiviral therapy.
Area of Science:
- Gastroenterology
- Virology
- Immunology
Background:
- Cytomegalovirus (CMV) colitis in inflammatory bowel disease (IBD) patients typically results from viral reactivation.
- Primary CMV infections are uncommon in adult IBD patients, and immunosuppressive therapy increases infection risk.
Observation:
- A 26-year-old female with underlying Crohn's colitis presented with symptoms suggestive of a primary CMV infection.
- Diagnostic findings included a positive CMV IgM titer, low-avidity IgG antibodies, high plasma CMV DNA levels, and immunohistological confirmation of CMV in the colon.
Findings:
- The patient received intravenous ganciclovir, leading to a decrease in plasma CMV DNA.
- Oral valganciclovir was administered for completion, resulting in undetectable plasma CMV DNA levels.
Implications:
- This case underscores the possibility of primary CMV colitis in adult IBD patients, even without a history of reactivation.
- Early diagnosis and prompt antiviral treatment are crucial for managing primary CMV colitis in IBD.
- Further research may elucidate risk factors and optimal management strategies for primary CMV infections in this population.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...

